Posterior-line Treatment With Disitamab Vedotin Plus PD-1 in Advanced HER2-low Expressing Gastric Cancer
Clinical trial NCT06078982 · UNKNOWN
Trial details
- NCT number
- NCT06078982
- Sponsor
- Shanghai East Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-06
- Primary completion
- 2025-08-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.